Indications (95)(?)
Sort by:
Default
-
Primary immunodeficiency (updated 2022)
▼
-
Thymoma immunodeficiency long term use (updated 2022)
▼
-
HSCT in primary immunodeficiencies – long term use (updated 2022)
▼
-
Specific antibody deficiency 6-12 month trial (updated 2022)
▼
-
Specific antibody deficiency beyond 6-12 months (updated 2022)
▼
-
Secondary antibody deficiency long term use (updated 2022)
▼
-
Neonatal alloimmune thrombocytopenia (updated 2022)
▼
-
Fetal-maternal Alloimmune Thrombocytopenia (updated 2022)
▼
-
Haemolytic disease of the newborn - short term use (updated 2022)
▼
-
Acute immune thromocytopenia (ITP) short term use (updated 2022)
▼